IMPROVING INDETERMINANT PULMONARY NODULE MANAGEMENT WITH THE PERCEPTA GENOMIC SEQUENCING CLASSIFIER
Sangeeta Bhorade(University of Chicago), Peter J. Mazzone(Cleveland Clinic), Travis Dotson, Hans C. Lee(The University of Texas MD Anderson Cancer Center), P. Sean Walsh(Veracyte (United States)), Christina Bellinger, Lori Lofaro(Veracyte (United States)), David Feller‐Kopman(Dartmouth–Hitchcock Medical Center), Jing Huang(Wuhan National Laboratory for Optoelectronics), Giulia C. Kennedy(Veracyte (United States)), Momen M. Wahidi(Northwestern University), Daniel G. Pankratz(Veracyte (United States)), Yoonha Choi(Ewha Womans University), Michael J. Bernstein
Cited by 0
Related Papers
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
|Cancer Cell|2012|652
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
|Nature Medicine|2020|593
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560